HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy

Dendritic cell (DC)-based immunotherapy is an attractive approach to induce long lasting antitumor effector cells aiming to control cancer progression. DC targeting is a critical step in the design of DC vaccines in order to optimize delivery and processing of the antigen, and several receptors have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zizzari, Ilaria Grazia, Veglia, Filippo, Taurino, Federica, Rahimi, Hassan, Quaglino, Elena, Belleudi, Francesca, Riccardo, Federica, Antonilli, Morena, Napoletano, Chiara, Bellati, Filippo, Benedetti-Panici, Pierluigi, Torrisi, Maria Rosaria, Frati, Luigi, Nuti, Marianna, Rughetti, Aurelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218291/
https://www.ncbi.nlm.nih.gov/pubmed/21845448
http://dx.doi.org/10.1007/s00109-011-0794-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218291/
https://www.ncbi.nlm.nih.gov/pubmed/21845448
http://dx.doi.org/10.1007/s00109-011-0794-7

Ejemplares similares